Topline phase 3 TRIUMPH-2 and TRIUMPH-3 trial data show robust weight loss and improved glycemic control with retatrutide in adults with T2D, obesity, and CVD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results